Skip to main navigation Skip to search Skip to main content

Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis

  • Hyeon Ju Ji*
  • , Sung Il Kim
  • , Jun Hee Lee
  • , Sang Il Lee
  • , Wan Hee Yoo
  • , Jung Yoon Choe
  • , Seung Hie Chung
  • , Jisoo Lee
  • , You Hyun Lee
  • , Shin Seok Lee
  • , Hyun Jung Yoon
  • , Chong Hyeon Yoon
  • , Ho Youn Kim
  • , Sung Hwan Park
  • *Corresponding author for this work
  • The Catholic University of Korea
  • Pusan University
  • Gyeongsang National University
  • Catholic University of Daegu
  • Ewha Womans University
  • Chonnam National University

Research output: Contribution to journalJournal articlepeer-review

Original languageEnglish
Pages (from-to)2094-2096
Number of pages3
JournalArthritis and Rheumatism
Volume56
Issue number6
DOIs
StatePublished - 2007.06

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Quacquarelli Symonds(QS) Subject Topics

  • Medicine
  • Pharmacy & Pharmacology
  • Biological Sciences

Cite this